Guided Therapeutics (GTHP) director receives 110,000 stock options at $0.29

Q: How many GUIDED THERAPEUTICS (GTHP) shares underlie Alan Grujic’s option grant?

Alan Grujic’s option grant covers 110,000 underlying shares of GUIDED THERAPEUTICS Common Stock. Each option corresponds to one share, providing future purchase rights subject to vesting and his continued service with the company through specified vesting dates.

Q: What is the vesting schedule for Alan Grujic’s GTHP stock options?

One-fourth of the options vested on March 10, 2026 . The remaining options vest monthly starting June 10, 2026 , contingent on continued service, and will be fully vested by March 9, 2029 , spreading the award over several years.

Q: When do Alan Grujic’s GUIDED THERAPEUTICS stock options expire?

Alan Grujic’s stock options expire on March 9, 2036 . After this expiration date, any unexercised options become worthless, so he must exercise vested options before then if he wishes to purchase shares at the fixed exercise price of $0.29.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

GUIDED THERAPEUTICS INC director Alan Grujic received a grant of stock options covering 110,000 shares of Common Stock. The options have an exercise price of $0.29 per share and expire on March 9, 2036, providing potential future equity if exercised.

According to the vesting terms, one-fourth of the options vested on March 10, 2026. The remaining options will vest in monthly installments starting on June 10, 2026, subject to Grujic’s continued service, until fully vested on March 9, 2029. This filing reflects a compensation-related award rather than an open-market purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Grujic Alan

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Options	110,000	$0.00	--

Holdings After Transaction: Stock Options — 110,000 shares (Direct)

Footnotes (1)

[object Object]

Key Figures

Options Granted: 110,000 options Exercise Price: $0.29 per share Underlying Shares: 110,000 shares +4 more

7 metrics

Options Granted 110,000 options Stock options award to director Alan Grujic

Exercise Price $0.29 per share Exercise price for Common Stock under option

Underlying Shares 110,000 shares Common Stock underlying the stock options

Expiration Date March 9, 2036 Option expiration date

Initial Vesting One-fourth on March 10, 2026 First tranche of options vested

Full Vesting March 9, 2029 Date when award becomes fully vested

Post-transaction derivative holdings 110,000 options Total options held after this grant

Key Terms

Stock Options, exercise price, vesting, Common Stock

4 terms

Stock Options financial

"security_title: "Stock Options""

Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

exercise price financial

"conversion_or_exercise_price: "0.2900""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting financial

"the remaining shares will vest monthly, starting on June 10, 2026"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Common Stock financial

"underlying_security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 Insider Transactions: What Each Field Means →

04/07/2026 - 05:10 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Grujic Alan

(Last)

(First)

(Middle)

5835 PEACHTREE CORNERS EAST

SUITE B

(Street)

PEACHTREE CORNERS

GEORGIA

30092

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GUIDED THERAPEUTICS INC [ GTHP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Options	$0.29	03/10/2026		A		110,000		⁽¹⁾	03/09/2036	Common Stock	110,000	$0.00	110,000	D

Explanation of Responses:

1. One-fourth of the shares subject to the award vested on March 10,2026; the remaining shares will vest monthly, starting on June 10, 2026, subject to the reporting person's continued service on each such date, until the award is fully vested on March 9, 2029.

Remarks:

	/s/ Alan Grujic	04/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did GUIDED THERAPEUTICS (GTHP) report for Alan Grujic?

GUIDED THERAPEUTICS reported that director Alan Grujic received a grant of 110,000 stock options. These options relate to Common Stock and represent a compensation award, not an open-market trade, aligning his potential upside with future company performance over a multi-year period.

What is the exercise price of Alan Grujic’s GTHP stock options?

The granted stock options to Alan Grujic have an exercise price of $0.29 per share. This means he can buy GUIDED THERAPEUTICS Common Stock at $0.29 if he exercises the options once they vest, potentially benefiting if the market price is higher.

How many GUIDED THERAPEUTICS (GTHP) shares underlie Alan Grujic’s option grant?

Alan Grujic’s option grant covers 110,000 underlying shares of GUIDED THERAPEUTICS Common Stock. Each option corresponds to one share, providing future purchase rights subject to vesting and his continued service with the company through specified vesting dates.

What is the vesting schedule for Alan Grujic’s GTHP stock options?

One-fourth of the options vested on March 10, 2026. The remaining options vest monthly starting June 10, 2026, contingent on continued service, and will be fully vested by March 9, 2029, spreading the award over several years.

When do Alan Grujic’s GUIDED THERAPEUTICS stock options expire?

Alan Grujic’s stock options expire on March 9, 2036. After this expiration date, any unexercised options become worthless, so he must exercise vested options before then if he wishes to purchase shares at the fixed exercise price of $0.29.